PDF) HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19
Flavio Leoni's research works | Italfarmaco, Milan and other places
Barbara VERGANI | Italfarmaco, Milan | research center | Research profile
Giovanni SANDRONE | Staff Scientist | Italfarmaco, Milan | Department of Medicinal Chemistry | Research profile
Barbara VERGANI | Italfarmaco, Milan | research center | Research profile
Difluoromethyl-1,3,4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity - Journal of Biological Chemistry
AU2017300486A1 - Benzo-N-hydroxy amide compounds having antitumor activity - Google Patents
US7235689B2 - Hydroxamic acid derivatives having anti-inflammatory action - Google Patents
PDF) ChemInform Abstract: Amino Acidic Scaffolds Bearing Unnatural Side Chains: An Old Idea Generates New and Versatile Tools for the Life Sciences
Amino acidic scaffolds bearing unnatural side chains: An old idea generates new and versatile tools for the life sciences
2020 #40 February
Frontiers | HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19
Amino acidic scaffolds bearing unnatural side chains: An old idea generates new and versatile tools for the life sciences
Amino acidic scaffolds bearing unnatural side chains: An old idea generates new and versatile tools for the life sciences
PDF) ChemInform Abstract: Amino Acidic Scaffolds Bearing Unnatural Side Chains: An Old Idea Generates New and Versatile Tools for the Life Sciences
Barbara VERGANI | Italfarmaco, Milan | research center | Research profile